Orion OyjORINF +4.81%100 Gross Margin % is 60.81% as of Mar. 2026, which is 1% above its 10-year median of 60.29. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $86.78. The stock has 2 warning signs investors should review. Among 938 Drug Manufacturers companies, Orion Oyj ranks better than 75.69% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Orion Oyj's Gross Profit for the
three
months ended in Mar. 2026 was $294 Mil. Orion Oyj's Revenue for the
three
months ended in Mar. 2026 was $483 Mil. Therefore, Orion Oyj's Gross Margin % for the quarter that ended in Mar. 2026 was 60.81%.
The historical rank and industry rank for Orion Oyj's Gross Margin % or its related term are showing as below:
ORINF'
s Gross Margin % Range Over the Past 10 Years
Min: 55.29 Med: 60.29 Max: 64.8
Current: 64.8
During the past 13 years, the highestGross Margin % of Orion Oyj was 64.80%. The lowest was 55.29%. And the median was 60.29%.
ORINF's Gross Margin % is ranked better than 75.69% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs ORINF: 64.80
Orion Oyj had a gross margin of 60.81% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Orion Oyj was 1.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Orion Oyj had a gross margin of 60.81% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Orion Oyj Gross Margin % Related Terms
Orion Oyj Gross Margin % Historical Data
* Premium members only.
The historical data trend for Orion Oyj's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ORINF vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, Orion Oyj's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Orion Oyj's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Orion Oyj (ORINF) has a Gross Margin % of 60.81% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Orion Oyj and its competitors. This is near median its historical median of 60.29. Over the past decade, Orion Oyj's Gross Margin % has ranged from 55.29 to 64.80. According to the industry distribution chart, Orion Oyj ranks #228 out of 938 companies in the Drug Manufacturers industry, placing it in the top 24.3%.
Is Orion Oyj's Gross Margin % too high?
Orion Oyj's current Gross Margin % of 60.81% is near median its 10-year median of 60.29. Over the past 10 years, this metric has ranged from a low of 55.29 to a high of 64.80. The Drug Manufacturers industry median Gross Margin % is 48.44. Orion Oyj's value of 60.81% is 25.5% above this industry median. Based on the distribution chart, Orion Oyj ranks #228 out of 938 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #228 out of 938 companies for Gross Margin %. This places Orion Oyj in the top 24% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.44. Orion Oyj's value of 60.81% is 25.5% above this benchmark. Historically, Orion Oyj's own Gross Margin % has ranged from 55.29 to 64.80 over the past decade. While the company's 10-year median is 60.29 vs. the industry median of 48.44, Orion Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current Gross Margin % of 60.81% is 25.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current Gross Margin % is 60.81%, which is near median its own 10-year median of 60.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Gross Margin % of 60.81%. The stock's GF Value™ is $86.78, compared to a current price of $82.75 — trading 4.6% below its estimated fair value. The current Gross Margin % is 60.81%, which is near median its 10-year median of 60.29 and 25.5% above the Drug Manufacturers industry median of 48.44. Orion Oyj's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Gross Margin % is 60.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued.
The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.
Key valuation signals for ORINF:
Gross Margin %: 60.81% (near median its 10-year median of 60.29)
GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
Industry Position: 25.5% above the Drug Manufacturers median (#228 of 938)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
